Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis. Alicandro G, Orena BS, Rosazza C, Cariani L, et al. Vaccine 2023 May 22:S0264-410X(23)00590-X. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Alicandro G, Orena BS, Rosazza C, Cariani L, et al. Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis. Vaccine 2023 May 22:S0264-410X(23)00590-X. doi: 10.1016/j.vaccine.2023.
PMID: 37263872